[Elsevier] [Supplementary]Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial |
|
This post will be closed automatically in 2026-08-03 07:17
Reward20points
|
post
reply
points
0
10
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00349-1/abstract
10
Safety profile of nivolumab-relatlimab in cancer patients: a living pharmacovigilance study of clinical trials and postmarketing data (version 1.0)
20
[Supplementary]Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
10
Basic principles of extrusion process
10
Basic principles of extrusion process
